A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- 4D Molecular Therapeutics
- Study ID
- NCT07867080
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Diabetic Macular Edema (DME)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 4D-150 IVT (3x10^10 vg) — BIOLOGICALIf randomized to the 4D-150 treatment arm, 4D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1
- EYELEA ® (aflibercept) Injection 2 mg (0.05mL) — BIOLOGICALEYLEA ® (aflibercept) will be administered at applicable visits
Study Details
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial to Evaluate the Safety, Efficacy, and Durability of a Single Intravitreal Injection of 4D-150 versus Aflibercept in Adults with Diabetic Macular Edema (4SIGHT)
Key Dates
- First listed
- Oct 9, 2026
- Start date
- Sep 18, 2026
- Status verified
- Oct 2026
- Primary completion
- Jan 31, 2029
- Completion
- Jan 31, 2030
Study Design
- Enrollment
- 514 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 4D-150 IVT (3x10^10 vg/eye)
- Active Comparator: Active Comparator (AFLB) 2mg IVT
Primary Outcome Measure
Mean change from baseline in Early Treatment Diabetic Retinopathy Study best-corrected visual acuity letter score at Week 52 [ Time Frame: 52 weeks ]
Central Contacts
- 4DMT Patient Advocacy(888) 748-8881
- 4SIGHT Medical Monitoring Distribution List
Locations (49)
Find similar trials in Scottsdale, AZ
Related Studies
- High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous VitrectomyPHASE4 · Recruiting · Retina Consultants of Orange County · Fullerton, California
- Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsPHASE4 · Enrolling By Invitation · Harrow Inc · Tyler, Texas
- A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTOPHASE3 · Recruiting · Kodiak Sciences Inc · Glendale, California
- A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular EdemaPHASE2 · Recruiting · BioAge Labs, Inc. · McAllen, Texas